|
|
Article: Targeted Patient Education
- Article from:
- Pharmaceutical Executive
- Article date:
- November 1, 2005
- Author:
CopyrightCopyright Advanstar Communications, Inc. Nov 2005. Provided by ProQuest LLC. (Hide copyright information)
|
Multiple sclerosis patients can benefit from a new kind of support system.
PATIENTS WITH CHRONIC diseases often lack easy access to specific information about their condition and treatment options. To keep patients better informed, some pharma companies have developed targeted patient-education programs. Serono, a biotech company specializing in treatments for multiple sclerosis (MS) (Rebif and Novantrone), among other therapeutic areas, launched a program in 2002 designed for patients with MS. The MSLifeLines program offers a call-center service, an interactive Web site (www.mslifelines.com), an ambassador program in which 90 MS patients serve as spokespeople to the MS community, and ...